State Of Alaska, Department Of Revenue Johnson & Johnson Transaction History

State Of Alaska, Department Of Revenue

$8.91 Billion
Q2 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Johnson & Johnson stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 374,023 shares of JNJ stock, worth $60.4 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

374,023

Previous 387,638 3.51%

Holding current value

$60.4 Million

Previous $61.3 Million 10.85%

% of portfolio

0.61%

Previous 0.7%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$144.38 - $157.78 $1.97 Million - $2.15 Million	-13,615 Reduced 3.51%	374,023 $54.7 Million
Q1 2024 Apr 19, 2024	SELL	$155.22 - $162.74 $4.52 Million - $4.73 Million	-29,095 Reduced 6.98%	387,638 $61.3 Million
Q4 2023 Jan 19, 2024	SELL	$145.6 - $158.88 $3.46 Million - $3.77 Million	-23,745 Reduced 5.39%	416,733 $65.3 Million
Q3 2023 Oct 16, 2023	SELL	$155.75 - $174.48 $5.37 Million - $6.02 Million	-34,480 Reduced 7.26%	440,478 $68.6 Million
Q2 2023 Jul 24, 2023	BUY	$154.35 - $166.11 $6.48 Million - $6.97 Million	41,965 Added 9.69%	474,958 $78.6 Million
Q1 2023 Apr 17, 2023	SELL	$151.05 - $180.26 $781,985 - $933,206	-5,177 Reduced 1.18%	432,993 $67.1 Million
Q4 2022 Jan 11, 2023	SELL	$160.2 - $179.79 $145,782 - $163,608	-910 Reduced 0.21%	438,170 $77.4 Million
Q3 2022 Oct 20, 2022	SELL	$161.33 - $179.52 $2.91 Million - $3.24 Million	-18,042 Reduced 3.95%	439,080 $71.7 Million
Q2 2022 Jul 08, 2022	BUY	$168.19 - $186.01 $3.55 Million - $3.93 Million	21,113 Added 4.84%	457,122 $81.1 Million
Q1 2022 Apr 14, 2022	SELL	$158.14 - $179.59 $2.1 Million - $2.39 Million	-13,288 Reduced 2.96%	436,009 $77.3 Million
Q4 2021 Jan 12, 2022	SELL	$155.93 - $173.01 $5.65 Million - $6.26 Million	-36,206 Reduced 7.46%	449,297 $76.9 Million
Q3 2021 Oct 07, 2021	BUY	$161.5 - $179.47 $1.83 Million - $2.04 Million	11,341 Added 2.39%	485,503 $78.4 Million
Q2 2021 Jul 12, 2021	SELL	$159.48 - $171.07 $8.45 Million - $9.07 Million	-52,991 Reduced 10.05%	474,162 $78.1 Million
Q1 2021 Apr 09, 2021	SELL	$153.07 - $170.48 $2.76 Million - $3.08 Million	-18,050 Reduced 3.31%	527,153 $86.6 Million
Q4 2020 Jan 08, 2021	SELL	$137.11 - $157.38 $3.75 Million - $4.31 Million	-27,365 Reduced 4.78%	545,203 $85.8 Million
Q3 2020 Oct 05, 2020	BUY	$140.38 - $153.83 $7.31 Million - $8.01 Million	52,056 Added 10.0%	572,568 $85.2 Million
Q2 2020 Jul 06, 2020	BUY	$128.81 - $155.51 $5.44 Million - $6.57 Million	42,234 Added 8.83%	520,512 $73.2 Million
Q1 2020 Apr 06, 2020	BUY	$111.14 - $153.99 $2.45 Million - $3.4 Million	22,088 Added 4.84%	478,278 $62.7 Million
Q4 2019 Jan 07, 2020	SELL	$127.5 - $146.44 $6.56 Million - $7.53 Million	-51,432 Reduced 10.13%	456,190 $66.5 Million
Q3 2019 Oct 02, 2019	BUY	$126.95 - $142.14 $20.7 Million - $23.1 Million	162,834 Added 47.23%	507,622 $65.7 Million
Q2 2019 Jul 23, 2019	BUY	$131.15 - $144.24 $991,625 - $1.09 Million	7,561 Added 2.24%	344,788 $48 Million
Q1 2019 Apr 09, 2019	SELL	$125.72 - $139.79 $2.83 Million - $3.15 Million	-22,535 Reduced 6.26%	337,227 $47.1 Million
Q4 2018 Jan 10, 2019	BUY	$122.84 - $147.84 $655,965 - $789,465	5,340 Added 1.51%	359,762 $46.4 Million
Q3 2018 Oct 09, 2018	SELL	$121.58 - $142.88 $1.8 Million - $2.12 Million	-14,840 Reduced 4.02%	354,422 $49 Million
Q2 2018 Jul 10, 2018	SELL	$119.4 - $131.76 $1.06 Million - $1.17 Million	-8,869 Reduced 2.35%	369,262 $44.8 Million
Q1 2018 Apr 19, 2018	SELL	$125.1 - $148.14 $3.84 Million - $4.55 Million	-30,690 Reduced 7.51%	378,131 $48.5 Million
Q4 2017 Jan 19, 2018	BUY	$131.22 - $143.62 $29.2 Million - $32 Million	222,804 Added 119.78%	408,821 $57.1 Million
Q3 2017 Oct 16, 2017	BUY	$129.47 - $135.38 $24.1 Million - $25.2 Million	186,017	186,017 $24.2 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $422B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Johnson & Johnson Transaction History